BRXTX
Price
$20.35
Change
+$0.21 (+1.04%)
Updated
Jun 2 closing price
Net Assets
4.85B
VTSNX
Price
$186.89
Change
+$1.14 (+0.61%)
Updated
Jun 2 closing price
Net Assets
629.15B
Interact to see
Advertisement

BRXTX vs VTSNX

Header iconBRXTX vs VTSNX Comparison
Open Charts BRXTX vs VTSNXBanner chart's image
BRXTX vs VTSNX Comparison Chart in %
View a ticker or compare two or three
VS
BRXTX vs. VTSNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXTX is a StrongBuy and VTSNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 629B vs. BRXTX (4.85B). VTSNX pays higher dividends than BRXTX: VTSNX (2.65) vs BRXTX (1.23). BRXTX was incepted earlier than VTSNX: BRXTX (11 years) vs VTSNX (16 years). BRXTX (0.78) is less costly to investors than VTSNX (0.06). BRXTX is a more actively managed with annual turnover of: 48.00 vs. VTSNX (4.00). BRXTX has a lower initial minimum investment than VTSNX: BRXTX (0) vs VTSNX (5000000). BRXTX annual gain was more profitable for investors over the last year : 34.58 vs. VTSNX (29.05). BRXTX return over 5 years is better than : 62.70 vs. VTSNX (35.32).
BRXTXVTSNXBRXTX / VTSNX
Total Expense Ratio0.770.061,283%
Annual Report Gross Expense Ratio0.780.061,300%
Fund Existence11 years16 years-
Gain YTD16.14814.645110%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B629B1%
Annual Yield % from dividends1.232.6546%
Returns for 1 year34.5829.05119%
Returns for 3 years84.8259.53142%
Returns for 5 years62.7035.32178%
Returns for 10 years155.41104.47149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.820.04
+2.25%
Innate Pharma SA
LRN97.911.41
+1.46%
Stride
CRCT4.16-0.23
-5.24%
Cricut
RVMD151.30-12.38
-7.56%
Revolution Medicines
HCWB1.79-0.28
-13.53%
HCW Biologics Inc